Table of Contents
International Journal of Molecular Imaging
Volume 2012, Article ID 484052, 5 pages
http://dx.doi.org/10.1155/2012/484052
Review Article

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography in Assessing Retroperitoneal Fibrosis: A Literature Review

1Institute of Nuclear Medicine, Catholic University of the Sacred Heart, Largo Gemelli, 00168 Rome, Italy
2Department of Nuclear Medicine, University of Brescia, Brescia, Italy

Received 29 June 2012; Revised 26 August 2012; Accepted 30 August 2012

Academic Editor: Laszlo Galuska

Copyright © 2012 Giorgio Treglia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background and Purpose. Several studies have evaluated the role of fluorine-18-fluorodeoxyglucose positron emission tomography and positron emission tomography/computed tomography (FDG-PET and PET/CT) in diagnosing and assessing disease activity in patients with retroperitoneal fibrosis (RF). The aim of our paper is to perform a literature review on this topic. Methods. Scientific articles that evaluated the usefulness of FDG-PET and PET/CT in patients with RF were searched and discussed. Results. Eleven studies were found, and the main findings of these articles were described. Conclusion. FDG-PET and PET/CT are useful functional imaging methods for assessing patients with RF both in the diagnosis and in the treatment response evaluation. Moreover, further studies are needed to substantiate the role of FDG-PET and PET/CT in patients with RF.